Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer

BACKGROUND: Chemotherapy-induced peripheral neuropathy is commonly observed in patients treated with nanoparticle albumin–bound paclitaxel (nab-PTX). We conducted a multicenter randomized controlled study to evaluate the optimal dose of nab-PTX. METHODS: We compared three different doses of q3w nab-...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsurutani, Junji, Hara, Fumikata, Kitada, Masahiro, Takahashi, Masato, Kikawa, Yuichiro, Kato, Hiroaki, Sakata, Eiko, Naito, Yoichi, Hasegawa, Yoshie, Saito, Tsuyoshi, Iwasa, Tsutomu, Taira, Naruto, Takashima, Tsutomu, Kashiwabara, Kosuke, Aihara, Tomohiko, Mukai, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753189/
https://www.ncbi.nlm.nih.gov/pubmed/33341707
http://dx.doi.org/10.1016/j.breast.2020.12.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753189/
https://www.ncbi.nlm.nih.gov/pubmed/33341707
http://dx.doi.org/10.1016/j.breast.2020.12.002

Ejemplares similares